CLINICAL TRIAL SUMMARY

MDACC Study No:2005-0781 (clinicaltrials.gov NCT No: NCT00498316)
Title:Cord Blood Expansion on Mesenchymal Stem Cells
Principal Investigator:Elizabeth Shpall
Treatment Agent:None
Study Status:Open
Study Description:The goal of this clinical research study your relative has agreed to
participate in, is to learn if culturing cord blood cells in the laboratory
will increase their number and thus will make the cells "take" faster in
recipients and improve the results of this form of transplantation.

Hide details for General InformationGeneral Information

Disease Group:Blood And Marrow Transplantation
Phase of Study:Phase I/Phase II
Treatment Agents:None
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:Patients will be at MD Anderson until day 100 posttransplant
Supported By:N/A
Return Visit:Every 6 months in year 1 and then yearly per standard of care follow-up
Home Care:none


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Elizabeth Shpall
Dept:Stem Cell Transplantation and Cellular Therapy
For Clinical Trial Enrollment:713-745-2161
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults